Kyowa Kirin Co (TSE:4151) Interest Expense : 円-302 Mil (TTM As of Sep. 2023)

View and export this data going back to 1949. Start your Free Trial

What is Kyowa Kirin Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Kyowa Kirin Co's interest expense for the three months ended in Sep. 2023 was 円 -90 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2023 was 円-302 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Kyowa Kirin Co's Operating Income for the three months ended in Sep. 2023 was 円 22,511 Mil. Kyowa Kirin Co's Interest Expense for the three months ended in Sep. 2023 was 円 -90 Mil. Kyowa Kirin Co's Interest Coverage for the quarter that ended in Sep. 2023 was 250.12. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Kyowa Kirin Co Interest Expense Historical Data

The historical data trend for Kyowa Kirin Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kyowa Kirin Co Interest Expense Chart

Kyowa Kirin Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Interest Expense

Get a 7-Day Free Trial

-1,390.00

-1,312.00

-299.00

-1,117.00

-1,088.00

Kyowa Kirin Co Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Interest Expense	Get a 7-Day Free Trial															-636.00	-164.00	-29.00	-19.00	-90.00

Kyowa Kirin Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-302 Mil.

Kyowa Kirin Co (TSE:4151) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Kyowa Kirin Co's Interest Expense for the three months ended in Sep. 2023 was 円-90 Mil. Its Operating Income for the three months ended in Sep. 2023 was 円22,511 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2023 was 円0 Mil.

Kyowa Kirin Co's Interest Coverage for the quarter that ended in Sep. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Sep. 2023 )	/	Interest Expense (Q: Sep. 2023 )
	=	-1	*	22511	/	-90
	=	250.12

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Kyowa Kirin Co Ltd has no debt.

Kyowa Kirin Co (TSE:4151) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kyowa Kirin Co Ltd (TSE:4151) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

KYKOY:USA KYKOF:USA

Address

1-9-2,Otemachi, Chiyoda-ku, Otemachi Financial City Grand Cube, Tokyo, JPN, 100-0004

Website

http://www.kyowa-kirin.com

Kyowa Kirin Co Ltd is a drug manufacturing company that focuses on biologic medicines. Its operations emphasize four categories: nephrology, oncology, immunology and allergy, and the central nervous system. The company has two reportable segments, Pharmaceuticals and Biochemicals. The pharmaceuticals business manufactures and sells ethical pharmaceuticals, diagnostic reagents, and other products. The biochemicals business manufactures and sells raw materials for pharmaceutical and industrial use, mainly amino acids, nucleic acids and related compounds, healthcare products, and others.

Kyowa Kirin Co (TSE:4151) Headlines

No Headlines